section name header

Introduction ⬇

Monoclonal immunoglobulins consist of heavy and light chains. IFE identifies presence or absence of a monoclonal protein and determines its heavy-chain and light-chain types.

This test measures immune status and competence by identifying monoclonal and particle protein band immunoglobulins involved in the immune response. IFE is a follow-up test performed when monoclonal spike is observed on SPEP or when a monoclonal gammopathy is suspected on the basis of the patient’s immunoglobulin concentrations.

Normal Findings ⬆ ⬇

Procedure ⬆ ⬇

  1. Collect a 7-mL blood serum sample in a red-topped tube or a 24-hour urine specimen. Observe standard precautions. Submit 25 mL from a 24-hour urine collection if a urine IFE is to be run simultaneously.

  2. If the IFE is a follow-up to a paraprotein being demonstrated by PEP (see Protein Electrophoresis [PEP], Serum and Urine), the same specimen (blood, urine, or both) used for the electrophoresis can be used for this procedure as well.

  3. In IFE, high-resolution electrophoresis produces stained bands. By comparing the location of the stained immunofixed band with a band in the same location in the SPEP reference pattern, a particular protein band can be identified.

Clinical Implications ⬆ ⬇

  1. Monoclonal protein in the serum or urine suggests a neoplastic process; a polyclonal increase in immunoglobulins is seen in chronic liver disease, connective tissue disease, and infection.

  2. With multiple myeloma, 99% of patients have a monoclonal protein in the serum or urine. Waldenström macroglobulinemia is characterized by the presence of a serum monoclonal IgM protein in all cases.

  3. A monoclonal light chain (K or Bence Jones protein) is found in the urine of about 75% of patients with multiple myeloma. Approximately 75% of patients with Waldenström macroglobulinemia have a monoclonal light chain in the urine. Heavy-chain fragments as well as free light chains may be seen in the urine of patients with multiple myeloma or amyloidosis.

Interventions ⬆

Pretest Patient Care

  1. Explain test purpose and specimen collection procedure.

  2. Submit the same specimen for the SPEP if a blood sample is needed. If the test is to be performed separately, another 7-mL blood sample collected in a red-topped tube is required. Note patient’s age; this procedure is seldom indicated in patients younger than 30 years because monoclonal proteins are rarely identified in this age group.

  3. A 24-hour urine specimen is preferred. Provide instructions and a 24-hour collection container (see Chapter 3 for protocols).

  4. Follow guidelines in Chapter 1 for safe, effective, informed pretest care.

Posttest Patient Care

  1. Review test results; report and record findings. Modify the nursing care plan as needed. Counsel the patient regarding abnormal findings; explain the need for possible follow-up testing and treatment. Continue to monitor for neoplasms, infection, and liver and connective tissue disease.

  2. Follow guidelines in Chapter 1 for safe, effective, informed posttest care.